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Purpose: Clinical studies have revealed that the most important predictor of successful 
bypass grafting is the origin and quality of the bypass conduit. Attempts at intraoperative 
evaluation of the hemodynamic properties of the conduit, including assessment ofblood 
flow (Q), pressure gradients (Ap), and resistance (R), have not been useful. This is 
because ach of these parameters measures the characteristics of the graft plus the outflow 
bed. To date, no specific measurement of the resistive properties of the conduit only is 
available. The purpose of this investigation was to evaluate longitudinal impedance (ZL) 
as a measure of conduit-specific resistance and to evaluate its potential in predicting the 
outcome of infrainguinal vascular reconstructions. 
Methods: ZL was measured during surgery in 73 infrainguinal utologous vein reconstruc- 
tions performed in 68 patients in two separate institutions over a 21-month period. Vein 
graft ultrasonic transit time Q and Ap (from proximal to distal anastomosis) were 
measured at baseline and after maximal peripheral vasodilatation with an intraarterial 
injection of papaverine 30 mg. Waveforms were recorded for 10 seconds at 200 Hz using 
a digital acquisition system. R was calculated as proximal mean pressure divided by mean 
blood flow (Q). After Fourier transformation, ZL was calculated as AP/Q at each 
harmonic and total Z L (fZL) was defined as the integral of moduli from 0 to 4 Hz. 
Results: All hemodynamic variables were significantly affected by papaverine vasodilata- 
tion (Ap, 3.9 +-- 0.5 vs 6.3 + 0.8 mm Hg; (~, 78.2 - 7.0 vs 126 + 11 ml/min; R, 134 - 
17 vs 72.7 - 6.2 × 103 dyne • sec • cm-S; p < 0.0001), except fZL, which remained 
constant (31.1 + 2.8 vs 30.8 - 2.8 x 103 dyne" cm-S; p = NS). After follow-up o f l  week 
to 17 months (median, 5 months), the 1-year primary, primary-assisted, and secondary 
patency rates were 72% - 7%, 77% + 6%, and 81% --- 6%, respectively. Using Cox analysis, 
primary patency was significantly associated with decreased fZ L (p = 0.0001), but not 
with baseline or papaverine-stimulated A~, (~, Ap/(~, or R. fZ L > 47 × 103 dyne. cm -s 
predicted primary failure with 90% positive and negative predictive value. 
Conclusions: Intraoperative measurement of fZ L in infrainguinal vein grafts is indepen- 
dent of outflow conditions (that is, does not change with papaverine), and hence 
describes the resistive properties of the conduit only. In addition, these preliminary data 
suggest that fZ L is predictive of short-term primary patency, fZ L is the first available 
hemodynamic measurement that is conduit-specific and may therefore be a better predic- 
tor of graft patency than currently available methods. (J Vase Surg 1997;25:1033-43.) 
Infrainguinal revascularization procedures have 
been increasingly applied to patients who have symp- 
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tomatic peripheral arterial insufficiency. Although 
technically successful in the majority of cases, vein 
graft failure continues to complicate 20% to 40% of 
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Fig. 1. Instrumentation f vein graft for the measure- 
ment ofZL. P2,ro~ Proximal pressure; Q, blood flow; Pai~, 
distal pressure. 
bypass attempts) 4 The mechanisms responsible for 
vein graft failure are poorly understood, although it 
has been suggested that the choice of conduit, ade- 
quacy of outflow, and the technical performance of 
the operation are the most critical factors. 
Considerable effort has been directed toward the 
intraoperative evaluation of the adequacy ofrevascu- 
larization procedures. Currently available methods 
include completion angiography, sq° measurement 
of the mean blood flow, ~>~8 flow waveform 
shape, 19-2s flow velocity, 26'27 resistance, ls 28-41 and 
impedance} 8,4244 All methods have been found to 
correlate with outcome to some degree. Completion 
angiography provides an assessment of the technical 
adequacy of anastomoses but yields no physiologic 
information. Each of the hemodynamic variables de- 
scribes, in some measure, the flow characteristics of
the bypass graft and outflow system. However, each 
is exquisitely sensitive to outflow conditions, and 
wide fluctuations in each parameter are routinely 
observed with pharmacologic or physiologic vasodi- 
latation. Therefore, the traditional hemodynamic 
measurements describe the properties of the conduit 
plus the outflow bed, and no variable is yet available 
that describes the hemodynamic properties of the 
conduit only. Because the adequacy of the bypass 
conduit is believed by many investigators to be one 
of the most critical elements of successful revascular- 
ization procedures, 1,45-49 accurate stimation of its 
specific resistive properties would be useful. The pur- 
pose of this study was to evaluate longitudinal im- 
pedance (ZL) as a measure of conduit-specific resis- 
tance and to evaluate its potential in predicting the 
outcome of infrainguinal vascular reconstruction 
procedures. 
METHODS 
Patients who underwent autologous infraingui- 
nal revascularization procedures at the Brigham and 
Women's Hospital (December 1994 to July 1995) 
or the University of Chicago (December 1995 to 
September 1996) were candidates for this study. 
Revascularization was performed in the standard 
fashion using reversed, in situ, or nonreversed 
greater saphenous, lesser saphenous, or upper ex- 
tremity vein according to the preference of the sur- 
geon. After completion of the anastomoses, two sep- 
arate 22-gauge cannulas were filled with saline 
solution and connected to standard pressure tubing 
and fluid-filled pressure transducers (Hewlett-Pack- 
ard; Palo Alto, Calif.). Each was calibrated to 100 
mm Hg using a hand-held mercury manometer. The 
cannulas were inserted into preserved venous side 
branches near the proximal and distal anastomoses 
for the purpose of measuring proximal (Pprox) and 
distal (Pdist) intraluminal blood pressure. An ultra- 
sonic transit-time probe (Transonics Systems, Inc., 
Ithaca, N.Y.) was used to measure blood flow (Q) in 
the region of the proximal vein graft (Fig. 1). Pp .... 
Pdist, and Q waveforms were simultaneously re- 
corded at 200 Hz for 10 seconds using a digital 
acquisition system (Lab Master D.M.A.; Scientific 
Solutions, Inc., Solon, Ohio). Data were obtained at 
baseline and after intragraft infusion ofpapaverine 30 
mg (Eli Lilly & Co., Indianapolis, Ind.). 
Hemodynamic calculations were performed after 
acquisition using software specifically designed for 
this purpose._Calculations i cluded mean pressure 
difference (Ap), mean blood flow ((~), mean graft 
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Fig. 2. Calculation of Z L in a femoropopliteal bypass. A, Waveforms. B, Z L curve. C, 
Calculation of fZ L (fZL = 10.5 × 103 dyne- cm-S). D, Comparison of Z L curves at baseline 
and after papaverine infusion. 
resistance (Ap/Q),  outflow resistance (R), and lon- 
gitudinal impedance (ZL). Rwas calculated as Pprox/ 
Q. Z L was calculated as Ap/Q at each harmonic after 
Fourier transformation of the respective waveforms. 
Fourier transformation is a mathematical technique 
that is useful for describing complex waveforms in 
more simple parameters. Complex waveforms in the 
time domain are broken down into a series of sine 
waves, each with a magnitude (modulus) and fre- 
quency. Details of the transformation are available 
elsewhere. 5°,51 After transformation of Ap and Q 
waveforms, a Z L curve was generated as Ap/Q at 
each harmonic, yielding the relationship of  Z L to 
frequency (Fig. 2). The first value or "mean compo- 
nent" (Z L at 0 frequency) is simply Ap/Q or "mean 
graft resistance." It represents graft resistance during 
steady-state flow without pulsatile components. The 
remainder of the curve describes the relationship of  
Ap /Q during pulsatile flow. To obtain a single value 
for "vein graft longitudinal impedance" (fZL) , the 
area under the curve from 0 to 4 Hz was determined 
by integration. The calculations required approxi- 
mately 10 seconds per data set to compute and were 
immediately available in the operating room for re- 
view. No grafts were modified or revised on the basis 
of impedance data. 
Data are presented as mean _+ SEM unless other- 
wise noted. Baseline and papaverine-stimulated h - 
modynamic measurements were compared using 
Student's t test for paired samples. Patency rates, 
limb salvage rates, and survival rates were calculated 
~asing the life table method. 6 The effect of  the clinical 
and hemodynamic variables on graft patency was 
assessed using either the log-rank test (for categorical 
variables) or the Cox method (for continuous vari- 
ables). The significant covariates were then selected 
as candidate predictors for multiple regression analy- 
sis. Forward stepwise Cox regression analysis was 
performed by the likelihood ratio test. p values less 
than 0.05 were considered significant. 
RESULTS 
A total of 73 grafts in 68 patients were enrolled. 
A summary of patient and vein graft demographics 
are given in Tables I and II. Impedance measure- 
ments were performed without complication in all 
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Table I .  Patient demographics (n = 68) 
Mean +_ SEM 
Variable (range) or n (%) 
Age (yr) 67 + 1 (36 to 95) 
Male 42 (62%) 
Coronary artery disease 33 (48%) 
Coronary artery bypass grafting 14 (21%) 
Hypertension 55 (81%) 
Diabetes mellitus 43 (63%) 
Insulin-dependent diabetes mellitus 28 (41%) 
End-stage renal failure 15 (22%) 
Cerebrovascular disease 16 (24%) 
patients; results are given in Table III. Stimulation 
resulted in stativtically significant increases in kp and 
0 and a decrease in R. There was no statistically 
significant difference between baseline and stimu- 
lated Ap/Q or fZL. 
Mean follow-up was 6 -+ 1 months (median, 5 
months; range, 1 week to 17 months). One-year 
primary patency, primary-assisted patency, secondary 
patency, limb salvage, and survival rates for the total 
patient group were 72% +- 7%, 77% +- 6%, 81% -+ 6%, 
81% -+ 7%, and 88% -+ 5%, respectively (Fig. 3). The 
secondary patency rate was equal to the limb salvage 
rate because two patients with end-stage renal failure 
required below-knee amputation despite patent 
grafts. 
The results of univariate analysis relating clinical 
and hemodynamic variables to primary patency are 
shown in Table IV. Elevated baseline fZL, elevated 
baseline Ap, infrainguinal proximal anastomosis 
level, elevated baseline AP/Q,  and elevated stimu- 
lated Ap were all associated with decreased primary 
patency rates. Using multiple regression analysis, 
however, only baseline fZ  L was significantly related 
to primary patency (p = 0.0001; Fig. 4). Although it 
was not statistically significant, veins that had been 
grafted into high-resistance outflow beds (as defined 
by stimulated R > 50 × 103 dyne • sec • cmS)  44 
appeared to have less favorable patency rates than 
grafts placed into low-resistance circuits (Fig. 5). 
Multiple regression analysis relating clinical and 
hemodynamic parameters to survival yielded ad- 
vanced age (p = 0.0062) and the presence of end- 
stage renal failure (p = 0.014) as the only indepen- 
dent predictors of death. None of the intraoperative 
hemodynamic measurements were related to survival 
by univariate or multiple regression analysis. 
A cut-off level of fZ  L was retrospectively chosen 
in an attempt o devise a useful clinical test. Grafts 
that were patent for at least 5 months (median fol- 
low-up) and all failed grafts were included in predic- 
Table II. Vein graft demographics (n = 73) 
Variable n (%) 
Institution 
Brigham and Women's 39 (53%) 
University of Chicago 34 (47%) 
Contralateral symptoms or surgery 41 (56%) 
Redo 14 (19%) 
Limb salvage indication 67 (92%) 
Proximal anastomosis level 
Groin 52 (71%) 
Infrainguinal 21 (29%) 
Distal anastomosis level 
Popliteal 11 (15%) 
Crural 54 (74%) 
Inframalleolar 8 (11%) 
Vein source 
Greater saphenous 48 (66%) 
Lesser saphenous 1 (1%) 
Cephalic/basilic 11 (15%) 
Composite 13 (18%) 
Vein direction 
NR 56 (77%) 
R 13 (18%) 
NR/R  2 (3%) 
R /NR 2 (3%) 
NR, Nonreversed; R, reversed. 
Table III. Vein graft hemodynamics 
Baseline Stimulated 
Variable (mean +- SD) (mean + SD) p 
X)prox (mm Hg) 75.2 -+ 16.2 73.4 -+ 17.3 0.015 
AP (mm Hg) 3.9 -+ 4.0 6.3 -+ 6.6 0.0001 
0 (ml/min) 78.2 _+ 58.7 126 _+ 89 0.0001 
AP/(~ (x 103 4.8 -+ 5.2 4.6 -+ 4.6 NS 
dynes, sec. cm -s) 
R(×10 a 134 _+ 140 72.7 _+ 52.3 0.0001 
dyne. sec. cm -s) 
fZL(×10 s 31.2 +-- 23.6 30.8 --+ 24.1 NS 
dyne" cm -~) 
*See text for descripnon. 
rive value analysis. A fZ  L value greater than 47 × 103 
dyne • cm -5 had a 90% positive and negative predic- 
tive value for primary failure. 
DISCUSSION 
The safety and efficacy of infrainguinal bypass 
grafting procedures have improved markedly in re- 
cent years. In large series, the mortality rate from 
infrainguinal bypass grafting approaches 2%, with the 
major morbidity rate estimated at about 7%. 4 The 
risk of immediate graft failure and limb loss remains 
at about 7%. The long-term outcome for infraingui- 
nal bypass procedures has also improved markedly, 
although failure rates varying from 20% to 40% at 5 
years are consistently reported. 1-4 As limb salvage 
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programs become more aggressive and grafts are 
placed to more distal vessels, the need for proper 
patient and conduit selection has become para- 
mount.  
Considerable attention has been given to the 
intraoperative assessment ofinfrainguinal revascular- 
ization procedures in an attempt o minimize post- 
operative failure. Early studies focused on the mea- 
surement o f  0 by electromagnetic flowimetry, 2 and 
the results indicated that grafts with adequate levels 
o f  0 exhibited superior patency rates at 3 
months il,13,17 and 1 year. ls,17,a2 More recent efforts 
have addressed the concept o f  functional "runotP' as- 
sessment hrough measurement o f  1k A variety of  
methods of  R estimation have been devised, with vari- 
able results. 29,31,33,36,s8,39,41 The available data suggest 
that high R correlates with graft failure at 1 month, s8 3 
months, 29 4 months, sl and i year. ss Its sensitivity and 
specificity are fairly low, however. 4,12-15,17,18,sz,s6, 
42,52,53 A recent study concluded that a stimulated R
value greater than 50 × l0 s dyne- sec" cm -s was 71% 
sensitive and 65% specific for graft failure at 2 years.  44 
This finding was reproduced in the present series 
Table IV.  Relationship o f  clinical and 
hemodynamic variables to primary patency 
(univariate analysis) 
Variable p 
Baseline fZ_L 0.0001 
Baseline Ap 0.0010 
Proximal anastomosis level 0.0037 
Baseline AP/_Q 0.014 
Stimulated Ap 0.020 
Vein source 0.098 
Presence of reversed vein segment 0.099 
Insulin-dependent diabetes mellitus 0.14 
Redo 0.14 
Coronary artery bypass grafting 0.18 
Stimulated Q 0.19 
Hypertension 0.22 
Distal anastomosis level 0.27 
Baseline R 0.36 
Diabetes mellitus (any type) 0.42 
Male 0.46 
Age 0.49 
Coronary artery disease 0.57 
Stimulated K 0.60 
Cerebrovascular disease 0.68 
End-stage renal failure 0.69 
Limb salvage indication 0.77 
Baseline Q 0.85 
Contralateral disease or reconstruction 0.86 
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statistically significant (p < 0.0001). Number of grafts at risk per interval is shown at bottom. 
(Fig. 5). Although the association is convincing, the 
fact that a significant number of grafts placed into 
high-resistive circuits remain patent limits its useful- 
ness as a clinical test. 
One possible explanation for the low sensitivity 
and specificity of Q and R measurements for graft 
failure is that they are strongly dependent on the 
resistive properties of the outflow bed and only 
wealdy dependent on the quality of the conduit. This 
can easily be demonstrated byinfusion of peripheral 
vasodilators, which have relatively little effect on the 
conduit but can change Ap, Q, and R by 100% 
(Table III). This report contains the first description, 
to our lmowledge, ofhemodynamic variables that are 
conduit-specific; that is, unaffected by changes in 
peripheral resistance. Vasodilatation i creases both 
Ap and Q, but their ratio remains constant (Table 
III). Traditionally, only the mean components o f  
vein graft resistance have been calculated (Ap/Q), 
although this method ignores the pulsatile nature of 
blood flow within grafts. Because the magnitude of 
the p ulsatile components of AP /Q actually exceed 
AP /Q (just as the systolic AP routinely exceeds AP), 
it seems reasonable to include the higher-frequency 
components of Ap /Q when evaluating the ability of 
a vein graft to carry blood, s4 Furthermore, in low- 
flow states, in conduits of a reasonable size, AP can 
be quite small and difficult to measure precisely, 
whereas the higher harmonics of Ap are greater in 
magnitude and can be measured with a lower signal- 
to-noise ratio. The calculation of fZ  L is therefore 
quite reproducible ven with profound changes in 
Ap, Q, and Rinduced by papaverine (Fig. 2, D). For 
these reasons, it is hypothesized that fZ  L more accu- 
rately reflects vein graft resistance than more tradi- 
tional variables, s
Given the strong dependence of successful revas- 
cularization procedures on conduit quality and given 
the conduit-specific nature o f fZ  D it is not surprising 
that fZ  L is a strong predictor of graft patency. Of all 
of the clinical and hemodynamic parameters exam- 
ined in this study, only fZ  L was significantly associ- 
ated with primary patency by multiple regression 
analysis. Of the 13 grafts in this series with high fZD 
nine failed primarily in less than 4 months. Two of 
the primary failures achieved primary-assisted pa- 
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tency through vein patch angioplasty, although one 
patient eventually required below-knee amputation 
with a patent graft. The other seven failures were 
treated by revascularization procedures with a new 
conduit (2), amputation (3), or observation (2). 
Four grafts that had high fZL remain patent at 1, 4, 
5, and 8 months, although one graft shows increased 
peak systolic velocity on duplex scan and revision is 
planned. In contrast, of the 60 grafts that had low 
fZL, only five failed, and three of the failures remain 
secondarily patent after thrombectomy, revision, or 
both. Thus a good quality conduit with a low fZ  L 
can often be successfully salvaged after an episode of 
thrombosis. As expected, none of the hemodynamic 
parameters were associated with patient survival, al- 
though advanced age and the presence of  end-stage 
renal failure were significant independent predictors 
of  death. 
CONCLUSION 
Intraoperative measurement of fZ  L in infraingui- 
nal vein grafts is independent of outflow conditions 
and therefore describes the resistive properties of the 
conduit only. These preliminary data suggest hat 
fZ  L is predictive of  short-term primary patency, fZ  L 
is the first available hemodynamic measurement that 
is conduit-specific and may therefore be a better 
predictor of graft patency than currently available 
methods. 
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DISCUSSION 
Dr. William M. Abbott (Boston, Mass.). As many of 
you know, this is an area of longstanding interest of mine 
and our research group, and I think this is a wonderful 
piece of work. I congratulate you on it. 
We tried to do this a number of years ago, and success 
was limited by virtue of technology. What you've done is 
take modern methods and prove what the mechanical 
engineers have known for years, that resistance is bad for 
.continuing blood flow. You have identified a group of 
high-impedance v ins that are destined to do poorly and 
some low-impedance v ins that are destined to do well. Of 
course, as I am sure you are also well aware, one of the 
things that governs impedance is not only the flow dynam- 
ics themselves but the wall mechanical properties. And as I 
am sure you are also aware, in the absence of diameter 
mismatches, that is stenoses, the likely cause of your high 
impedance is low compliance of the vein wall. So I think it 
would be a very interesting next step, if you haven't already 
done it, to correlate the viscoelastic or compliance proper- 
ties of the conduits with your results. Once you do that, I
think that you'll then be able, in the operating room, to 
have identified a set of circumstances that will at least let 
you say to yourself when you leave the operating room, "if 
this doesn't work, I have to do something totally different 
rather than spending a long period of time trying to fix the 
problem, because it's fundamentally a bad conduit." 
The other thing that I think would be very interesting 
for you to do, because the compliance values of prostheses 
are so much different han that of vein, would be to 
compare those. It has been a longstanding hypothesis of 
ours that compliance mismatch is one of the contributors 
to the poor results of prosthetic bypass grafts in the lower 
extremities. Thus I would ask you whether you've had any 
experience in doing these measurements in prostheses. 
Dr. Lewis B. Schwartz. We have actually approached 
both of those issues, the first being the possible relation- 
ship with viscoelastic properties. We have set up an in vitro 
system in the laboratory, and because the longitudinal 
impedance is independent of both the input and outflow 
conditions, it is very easy to measure longitudinal imped- 
ance in the laboratory. We have been unable to correlate 
longitudinal impedance with diameter, interestingly, al- 
though our sample size is small. We have also been unable 
to correlate ZLwith wall characteristics upto this point, but 
I agree completely that compliance is going to be a major 
determinant of longitudinal impedance and vice versa. 
As far as prosthetic grafts, we have done two intraoper- 
ative measurements of polytetrafluoroethylene grafts, and 
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the resistance is very low. It is a very large conduit, and 
there is practically no pressure gradient. It is interesting 
that the shape of the curve does not approach the shape of 
a vein graft curve. It's perfectly fiat all across the frequency 
spectrum. I don't know whether that has anything to do 
with its propensity to failure, but it is a very, if you'll excuse 
the term, unnatural-appearing longitudinal impedance 
curve, so we are currently investigating that as well. 
Dr. James O. Menzoian (Boston, Mass.). This is a 
very interesting paper, Dr. Schwartz, and I think that any 
time you hear about what keeps grafts open or why grafts 
fail it gets our attention. My own interest in measuring the 
runoff stems back many years ago when Dr. Mannick used 
to measure flow in all the vein grafts he did, and I was really 
impressed by the fact that in those days when we per- 
formed bypass procedures to an isolated popliteal segment 
and the flow in the graft was extremely low--20 or 25 
ml--and those grafts would still stay open. So I sort of 
came to the conclusion, and he taught me that vein grafts 
are good and that there "ain't nothing like the real thing, 
baby." I may have taken a little liberty with what Dr. 
Mannick actually said, but vein grafts are good. 
Dr. John A. Mannick (Boston, Mass.). I wish I would 
have said that. 
Dr. Menzoian. There are a couple of things that I 
don't understand here. This impedance is actually a calcu- 
lated value and you calculate it from Ap and you calculate it
from flow, and yet when you correlated what kept a graft 
patent, the only thing that correlated was the impedance 
value and it didn't correlate with change in pressure and it 
didn't correlate with flow. Somehow, I don't understand 
the math of that. If they are related and all calculated, why 
don't they all correlate? 
Dr. Schwartz. The reason is that it is not really impor- 
tant what the flow is. You yourself said grafts with low flow 
stay open, and if you don't like the flow that you have in 
your bypass graft, give some papaverine and the flow will 
go up. The change in pressure is not really important 
either, because at low flow the change in pressure will be 
low and if you stimulate flow the change in pressure will be 
higher. What's important is the ratio of those two. It is the 
ratio of the change in pressure to flow, and that is why in a 
multivariate analysis both flow and the change in pressure 
will cancel out, but their quotient will remain important. 
Dr. Menzoian. Another interesting point, if I may 
continue, I was really intrigued by the fact that nothing 
correlated with patency other than this measurement, not 
diabetes, not renal failure, not above-knee, not in situ, not 
reversed. Nothing correlated other than this measurement. 
Weren't you a little surprised by that? 
Dr. Schwartz.. The data are the data, but I will add 
that none of those variables correlate with longitudinal 
impedance, ither. We looked whether cephalic veins had a 
lower longitudinal impedance because they were larger. 
That doesn't hold true. Maybe veins had a different longi- 
tudinal impedance depending on whether or not you had 
diabetes or high blood pressure. That doesn't seem to hold 
true, and it sort of goes with the clinical observation that 
it's a little hard to predict who will have a good vein and 
who will have a bad vein. Even with vein mapping, frankly, 
I find it hard to predict. 
Dr. Menzoian. What you are saying is that this mea- 
surement of a 60 cm long graft is more important than the 
entire runoff bed, which is probably a couple of million 
miles of capillaries. That's a little interesting to me. Why do 
you think that is the case? 
Dr. Schwartz. Well, I think there are many people in 
this room who think that the quality of the vein is maybe 
the most or one of the most important factors in bypass 
grafting. You say yourself, Dr. Menzoian, that grafts with 
very low flow can still stay open if it's a good vein. So I 
frankly am not surprised at the relative importance of 
something that measures the quality of the vein com- 
pared to something that measures the quality of the 
outflow. 
Dr. George D. LeMaitre (North Andover, Mass.). I 
congratulate he authors on attempting to derive physio- 
logic data during surgery on bypass grafts. That's the way 
to go in the future. 
In our operating room, we simultaneously measure 
proximal and distal graft flow to gauge the significance of 
the residual fistulae that we leave behind. Needless to say, 
the more fistulae, or the more significant they are, or the 
less resistance to flow in them, the more discrepancy we 
end up with between the two flowmeters, and that helps to 
determine whether we have to bother ligating them. Were 
any of the grafts in your series in situ grafts, and if so were 
fistulae there when you made your measurements? 
Dr. Schwartz. They were all tied off. Some grafts were , 
performed in situ, but all the fistulae were fled. 
Dr, LeMaitre. When they were in situ they were all 
tied off, which was a pure vein measurement? 
Dr. Schwartz. Yes. I wouldn't know how to interpret 
the data otherwise. 
Dr, Frank W. LoGerfo (Boston, Mass.). When you 
talk about resistance, are you talldng about resistance 
across the graft? 
Dr. Schwartz. Yes. 
Dr, LoGerfo. And there is no relationship between 
resistance across the graft and graft patency, but there is a 
relationship between the longitudinal impedance and graft 
patency? 
Dr. Schwartz. Longitudinal impedance and resistance 
across the graft are synonymous, o there is a relationship 
between resistance across the graft. 
Dr. LoGerfo. So why don't we just measure pressure 
and flow across the graft? 
Dr. Schwartz. If you have a graft hat is about 4 mm in 
diameter and it has 50 ml/min of flow going through it, 
then the mean pressure difference will only be about 1, and 
it's very difficult o measure that very accurately. We know 
that mean pressure differences are not that important be- 
cause we often talk about systolic pressure differences. In 
other words, the difference in pressure at 1 Hz is more 
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important than the difference in pressure at the mean value, 
and so it is much easier if you take the entire flow wave 
form to measure the pressure difference across the graft, 
and the reason we measure harmonics at all is because it 
turns out to be more precise than just measuring a simple 
mean pressure difference. 
Dr. Wil l iam W. Babson, Jr. (Plymouth, Mass.). I 
think this is an exciting paper because one thing it might 
do is take the onus of thrombosed graft from the technical 
aspects of the surgeon and put it on the graft, but the 
question that I have is what do you mean by measuring at 
different harmonics? How do you determine what har- 
monic? What is 1 Hz and 4 Hz? What does that mean? 
Dr. Schwartz. It would take a couple of hours and 
people a lot smarter than me to explain that, but blood 
flows at say 60 beats per minute and the peak of that would 
be 300 ml per minute, whereas the mean might be 50 ml 
per minute. Well, if you only measure the mean and that's 
at 0 harmonic or 0 frequency, you are missing all this 
information that is contained within this wave form that is 
very complex, and Fourier analysis is a way to take that 
complex wave form in a time domain and transform it into 
a frequency domain, so we can talk about the component 
at 1 Hz or the fundamental frequency, the component at 2 
Hz, 3 Hz, because these wave forms have very complex 
components to them, so you are missing all this informa- 
tion by simply taking the mean component at 0 Hz. 
Dr. Frank J. Veith (Bronx, N.Y.). You say that the 
impedance did not correlate with the diameter of the vein. 
Did you look also at the disease within the vein that may 
have accounted for this impedance? Maybe you are just 
picldng up those veins that have preexisting syncytial webs 
and other luminal esions. I believe it would be interesting 
to use angioscopy and see whether there is an anatomic 
reason within the vein graft that produced the high imped- 
ance. Did you do that at all? Any idea of pathologic har- 
acteristics? 
Dr. Schwartz. We did not. 
Dr. Veith. I believe there is something inside the vein 
or the vein wall that accounts for this, and I believe you 
have a sophisticated way of detecting that. 
Dr. Schwartz. Well, I agree completely. 
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